Expert think tank on immuno-oncology - An initiative by MSD and Nationale Strategie gegen Krebs (NSK)

Lucerne, 10th July 2017 - What changes are necessary in order to fully exploit the potential of immuno-oncology for the benefit of the patient and the quality of care? This and similar questions were addressed by an expert think tank, a joint initiative of MSD and Nationale Strategie gegen Krebs (NSK) and composed of experts from the fields of medicine, research, care, patient organisations, relatives, health insurance and industry. The think-tank has recently published concrete recommendations on how these changes can be achieved. The publication in German can be found here (PDF).

More information is available at: www.msd.ch

Press contact:
Dr. Angelika März, Director Policy & Communications
MSD Merck Sharp & Dohme AG
Tel. +41 58 618 35 18 / Mobile 079 378 02 47
media.switzerland@merck.com

© 2017 MSD Merck Sharp & Dohme AG, Werftestrasse 4, 6005 Luzern. All rights reserved.

CORP-1242200-0000, July 2017